Burning Rock Biotech (BNR) Non Operating Investment Income (2019 - 2020)

Burning Rock Biotech (BNR) posted quarterly Non Operating Investment Income of $501937.0 for Q1 2020, up 5196.08% year-over-year from $9477.5 in Q2 2019, and up 406.83% on a QoQ basis from -$163588.5 in Q4 2019.

Burning Rock Biotech (BNR) Non Operating Investment Income (2019 - 2020) Analysis & Trends

Burning Rock Biotech (BNR) has reported Non Operating Investment Income for 2 consecutive years, with $501937.0 the latest figure, recorded in Q1 2020.

  • In Q1 2020, Non Operating Investment Income rose 5196.08% year-over-year to $501937.0; the TTM figure through Dec 2020 stood at $501937.0 (up 223.88% YoY), while the FY2020 annual figure was $537000.0, up 230.6% from the prior year.
  • Non Operating Investment Income came in at $501937.0 for Q1 2020 at Burning Rock Biotech, up from -$163588.5 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $501937.0 in Q1 2020, with the low at -$200164.1 in Q3 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn -
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn -
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn -
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn -
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn -
10 Burning Rock Biotech 748.66 Mn 683.48 Mn 11.31 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2020 501,936.97
Mar 31, 2020 501,936.97
Dec 31, 2019 -163,588.53
Dec 31, 2019 -163,588.53
Sep 30, 2019 -200,164.08
Sep 30, 2019 -200,164.08
Jun 30, 2019 -50,910.35
Jun 30, 2019 -50,910.35
Mar 31, 2019 9,477.51
Mar 31, 2019 9,477.51